Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimizing Malaria Treatment for HIV-Malaria Co-Infected Individuals
NCT04708496Phase 4Unknown
- Sponsor
- Makerere University
- Start
- Jan 2021
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of artemether + lumefantrine in malaria, sponsored by Makerere University. Status: unknown.
02
Drugs
artemether + lumefantrine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT04708496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04708496.